Health In Tech, Inc. Class A Common Stock (HIT)vsSAP SE ADR (SAP)
HIT
Health In Tech, Inc. Class A Common Stock
$0.56
-3.30%
TECHNOLOGY · Cap: $37.47M
SAP
SAP SE ADR
$233.45
-4.14%
TECHNOLOGY · Cap: $272.16B
Smart Verdict
WallStSmart Research — data-driven comparison
SAP SE ADR generates 119884% more annual revenue ($39.39B vs $32.83M). SAP leads profitability with a 20.4% profit margin vs -12.0%. SAP earns a higher WallStSmart Score of 60/100 (C).
HIT
Avoid30
out of 100
Grade: F
SAP
Buy60
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HIT.
Margin of Safety
-25.4%
Fair Value
$156.60
Current Price
$233.45
$76.85 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Mega-cap, among the largest globally
Safe zone — low bankruptcy risk
Keeps 20 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Strong operational efficiency at 29.5%
Generating 1.7B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -3.7% — below average capital efficiency
Revenue declined 13.5%
Expensive relative to growth rate
Moderate valuation
Trading at 73.2x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : HIT
The strongest argument for HIT centers on Debt/Equity, Altman Z-Score, Price/Book.
Bull Case : SAP
The strongest argument for SAP centers on Market Cap, Altman Z-Score, Profit Margin. Profitability is solid with margins at 20.4% and operating margin at 29.5%. Revenue growth of 13.2% demonstrates continued momentum.
Bear Case : HIT
The primary concerns for HIT are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : SAP
The primary concerns for SAP are PEG Ratio, P/E Ratio, Price/Book.
Key Dynamics to Monitor
HIT profiles as a turnaround stock while SAP is a mature play — different risk/reward profiles.
SAP is growing revenue faster at 13.2% — sustainability is the question.
SAP generates stronger free cash flow (1.7B), providing more financial flexibility.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SAP scores higher overall (60/100 vs 30/100), backed by strong 20.4% margins and 13.2% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Health In Tech, Inc. Class A Common Stock
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Health In Tech, Inc. (HIT) is a leading innovator in the digital health sector, dedicated to enhancing healthcare delivery through advanced technology solutions. The company leverages state-of-the-art data analytics and proprietary software to empower healthcare providers and patients alike, facilitating informed decision-making and improved operational efficiencies. With a strong commitment to compliance and cybersecurity, HIT is adept at addressing the challenges of the rapidly evolving digital health environment. As the industry continues to grow, HIT is strategically positioned to capitalize on emerging opportunities, playing a pivotal role in the global advancement of technology-driven healthcare solutions.
SAP SE ADR
TECHNOLOGY · SOFTWARE - APPLICATION · USA
SAP SE is a global enterprise application software company. The company is headquartered in Walldorf, Germany.
Visit Website →Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?